Lecture 7 Flashcards

Ch6 Growth inhibition and tumor suppressor genes

1
Q

What is PTEN?

A

A tumor suppressor protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When is the loss of PTEN not a problem?

A

When EGF (a growth signal) is gone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What can an EGFR mutation lead to?

A

To an oncogene, whjch signals without needing EGF binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the Knudson’s two-hit hypothesis?

A

When you need a mutation in both TSG for it to lead to cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is familial cancer different then normal cancer?

A

Familial cancer is more frequent and occurs earlier as there is only one additional mutation needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is haploinsufficieny?

A

Some TSG only need one mutation, eg p53

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which cancers belong to the proteins RB1, p53, APC and BRCA

A

RB1 = retinoblastoma
p53 = Li-Fraumeni
APC = colorectal cancer
BRCA = breast and ovarian cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can E2F be released from Rb?

A

Release via phosphorylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is E2F needed for?

A

For transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which factors can lead to no cell cycle regulation (by E2F)?

A

When pRB is lost, when there is a mutation in the pocket region of pRB, hyperphosphorylation of pRB (common) and binding of an oncogene virus to pRB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are upstream activators of p53?

A

There is deregulation: eg DNA damage, oncogene activation and cell stress (are sensors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are downstream effects of p53?

A

There is restauration or suicide: eg cell cycle arrest, DNA repair, apoptosis, inhibit angiogenesis (are effectors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does p53 do to work?

A

It has to form tetrameres

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which four domains can be found in a p53 gene?

A

Tetramerization domain, DNA binding domain (promoter), transactivation (transcription) and MDM3 (inhibits p53) domain and regulatory domain (cofactor binding)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the effect of p53 binding to MDM2?

A

It drives the export of p53 out of the nucleus, then ubiquitination and degradation of p53, so usually p53 has lower levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What drives the expression of MDM2?

A

p53

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the effect of stress on p53?

A

It leads to production of more p53, which has a fast and strong effect and eventually there will also be more MDM2

18
Q

What happens after DNA damage and cell stress?

A

Kinases are activated, which phosphorylate p53 to dislodge MDM2

19
Q

What happens after oncogene activation?

A

This activates molecules that bind to MDM2 with a higher affinity than p53, which frees p53

20
Q

How does p53 introduce cell cycle arrest?

A

By binding of p53 to p21, which binds to a cyclin inhibitor, which binds to pRB. This means that pRB cannot be phosphorylated, thus E2F cannot be released

21
Q

How does p53 introduce intrinsic apoptosis?

A

It releases cytochrome c from the mitochondria and suppresses anti-apoptotics (eg BCL2)

22
Q

How does p53 introduce extrinsic apoptosis?

23
Q

What other molecule does p53 work on?

24
Q

Which p53 factors target gene selectivity?

A

Amount, modification, co-factor of promoter or p53

25
Q

How does the difference in promoter binding affinity influence the gene selectivity?

A

eg p21 has a high affinity for p53, anti-apoptotics have a low affinity

26
Q

How do cofactors binding to the promoter influence the gene selectivity?

A

By eg MIZ-I binding to the promoter of p21

27
Q

How do cofactors binding to p53 influence the gene selectivity?

A

ASPP binds to p53 and increases the affinity for pro-apoptotic promoters

28
Q

What is the function of Myc oncogenes (in cancer) do to prevent p53 activation?

A

It binds to MIZ-I with a higher affinity than p53

29
Q

In which domain can about 90% of the mutations be found?

A

In the DNA binding domain

30
Q

What other way is there to prevent p53 apart from mutations?

A

By inhibiting other proteins, either endogenous or viral

31
Q

What is a dominant negative p53 mutation?

A

This mutated p53 can form a tetramer with the WT, but when one mutated protein is in the tetramer it becomes transcriptionally inactive. There is p53 accumulation, as less MDM2 is produced

32
Q

What is a gain-of-function mutation in p53?

A

p53 binds to promoters that contribute to carcinogenesis and it activates them

33
Q

What does the viral DNA do with Rb and E2F

A

One protein inhibits RB + release of E2F and a second protein blocks p53, so it cannot go into cell cycle arrest and produce new viral DNA

34
Q

Which proteins of HPV inhibit what?

A

E7 inhibits RB, E6 inhibits p53

35
Q

Which proteins of Adenovirus inhibits what?

A

E1A inhibits RB, E1B inhibits p53

36
Q

What is needed for the maintenance of cancer?

A

The continues inhibition of p53

37
Q

How can p53 be used for cancer treatment?

A

Restoring the activity of p53

38
Q

Which ways are there of using p53 activity as treatment?

A

Introducing functional p53, restore protein conformation, oncolytic adenovirus introduction, inhibitor of MDM2

39
Q

What is the problem with the introduction of functional p53?

A

It is hard to introduce it into all the cancer cells

40
Q

Which molecules can be used to restore protein conformation?

A

PRIMA-1 or APR-246

41
Q

How can oncolytic adenovirus be used to restore p53 activity?

A

It is introduced without E1B, so it will not kill normal cells, but it will cancer cells

42
Q

How can an inhibitor be used to restore p53 activity?

A

MDM2 binds to the inhibitor (eg nutlin) when p53 is still active